Skip Navigation

Nutrifill Recall Lawsuit Alleges Compromised Sterile Lens Solution Resulted in Loss of Sight

Nutrifill Recall Lawsuit Alleges Compromised Sterile Lens Solution Resulted in Loss of Sight

A Texas man has filed a product liability lawsuit alleging that contaminated Nutrifill preservative-free contact lens solution caused a severe eye infection that left him blind in one eye and in need of a corneal transplant.

The complaint (PDF) was originally brought by David Maloy in Texas District Court on December 2, 2025, naming Contamac Solutions Inc., Contamac U.S. Inc. and Asept Pak Inc. as defendants. The case was later removed to the U.S. District Court for the Eastern District of Texas on February 17.

According to the lawsuit, the defendants manufacture or distribute Nutrifill solution, a preservative-free sterile saline product intended for filling and rinsing certain contact lenses.

However, in May 2025, Maloy says he received a recall notice warning him to stop using specific Nutrifill products because they “may not be sterile.” The notice referenced reports of serious eye injuries, including corneal ulcers. According to the complaint, federal regulators were notified and multiple product lots were recalled after testing identified non-sterile samples, raising concerns about possible contamination during the manufacturing process.

Maloy’s allegations mirror claims raised in a series of Nurse Assist SteriCare lawsuits filed over the past year, in which plaintiffs allege that contaminated sterile water and saline products led to serious, and in some cases fatal, infections.

Saline-Sterile-Water-Recall-Lawyers
Saline-Sterile-Water-Recall-Lawyers

According to his complaint, Maloy began using Nutrifill Preservative Free Scleral, Hybrid and Gas Permeable (GP) Lens Insertion Solution in September 2022, nearly three years prior to receiving the recall notice.

However, the complaint indicates that on October 24, 2024, Maloy developed catastrophic eye complications. He was diagnosed with a corneal ulcer and endophthalmitis in his left eye, which resulted in significant vision loss and ultimately blindness. According to the lawsuit, he now suffers from ongoing hypersensitivity to light, persistent pain and has required intensive inpatient and outpatient treatment.

Maloy contends that he used the recalled solution while inserting his contact lenses between September 2022 and October 2024, and that the compromised sterility allowed contaminants to enter his eye, leading to infection and permanent vision damage. According to the filing, his physicians have recommended that he undergo a corneal transplant.

The lawsuit alleges that the Nutrifill solution was marketed as preservative-free and suitable for inserting specialty contact lenses, yet was unreasonably dangerous due to non-sterility at the time it left defendants’ control. The filing asserts that defendants failed to implement adequate quality control and testing procedures, failed to identify and notify users of contamination in a timely manner, and placed the product into the stream of commerce despite foreseeable risks.

“After the fact, around May 2025, Plaintiff received a recall notice from Defendant Contamac Solutions, stating he was to discontinue use of the Nutrifill products due to the Nutrifill products may not be sterile, and that it had received 23 serious injuries that the product may have contributed to the infections resulting in corneal ulcers.”

David Maloy v. Contamac Solutions Inc. et al

The complaint raises allegations of negligence, breach of implied and express warranty, as well as strict product liability for manufacturing defects and failure to warn. It seeks damages for past and future medical expenses, physical pain, mental anguish, disfigurement, physical impairment and lost earning capacity.

Nurse Assist Sterile Water Lawsuits

Maloy’s complaint comes amid heightened scrutiny of sterile solution products, following several high-profile recalls that have sparked litigation.

Among them are nationwide SteriCare sterile water lawsuits filed against Amazon and other distributors after a November 2023 recall of Nurse Assist saline and sterile water products linked to a packaging seal defect that may have compromised sterility and allowed bacteria to contaminate the solutions.

As a result, individuals who used a recalled Nurse Assist product and later experienced any of the following symptoms may be eligible to pursue compensation:

  • Sepsis or septic shock
  • Bloodstream infections
  • Respiratory infections
  • Organ failure
  • Necrosis or serious wound-related infections
  • Prolonged hospital stays or additional surgeries

Product liability lawyers are currently reviewing claims on behalf of individuals who developed infections after using compromised Nurse Assist products.

Sign up for more legal news that could affect you or your family.

Written By: Michael Adams

Senior Editor & Journalist

Michael Adams is a senior editor and legal journalist at AboutLawsuits.com with over 20 years of experience covering financial, legal, and consumer protection issues. He previously held editorial leadership roles at Forbes Advisor and contributes original reporting on class actions, cybersecurity litigation, and emerging lawsuits impacting consumers.



0 Comments


This field is for validation purposes and should be left unchanged.

Share Your Comments

This field is hidden when viewing the form
I authorize the above comments be posted on this page
Post Comment
Weekly Digest Opt-In

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

MORE TOP STORIES

Plaintiffs are asking a federal panel to consolidate a growing number of spinal cord stimulator lawsuits against Abbott and Boston Scientific, alleging defective design changes caused lead fractures, device failures and neurological injuries nationwide.
A New York woman has filed a lawsuit alleging that her long term use of Depo Provera caused her to develop a meningioma brain tumor, which she contends resulted from the manufacturer’s negligence and failure to adequately warn about the risks.
A group of plaintiffs has petitioned the U.S. Judicial Panel on Multidistrict Litigation to centralize all Dupixent lymphoma lawsuits before a single judge for coordinated pretrial proceedings, a move that could ultimately lead to bellwether trials and a global resolution of the claims.

About the writer

Michael Adams

Michael Adams

Michael Adams is a senior editor and legal journalist at AboutLawsuits.com with over 20 years of experience covering financial, legal, and consumer protection issues. He previously held editorial leadership roles at Forbes Advisor and contributes original reporting on class actions, cybersecurity litigation, and emerging lawsuits impacting consumers.